Virtually all pharmaceutical manufacturers have robust policies to place needed medicines in the hands of those who cannot afford to pay for them.
PRESIDENT | CORBETT WORLDWIDE HEALTHCARE COMMUNICATIONS
Ironically, pharma has many patient assistance programs already firmly in place (established well before the current economic downturn). There is probably no other industry in America that has as many established initiatives to assure continuity of care for the customer.
Virtually all pharmaceutical manufacturers have robust policies to place needed medicines in the hands of those who cannot afford to pay for them. Although this is certainly not an exhaustive list, what follows is merely a portion of the programs that pharma has sponsored to safeguard the health of patients: the AstraZeneca Prescription Savings Program, the Merck Patient Assistance Program, the Alcon U.S. Patient Assistance Program, the Pfizer Friends Program, the Bristol-Myers Squibb Patient Assistance Foundation, the Procter & Gamble Pharmaceuticals Patient Assistance Program, and the Sanofi-Aventis Patient Assistance Program. Perhaps pharma needs to "toot its own horn" a little more loudly and recognize that those of us who work in the pharmaceutical industry are dedicated to extending and enhancing human life.
Elaine Eisen
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
MDMA Therapy for Mental Health Conditions: Do the Benefits Outweigh the Risks?
October 25th 2024Despite a recent FDA Complete Response Letter issued to Lykos for midomafetamine capsules for the treatment of post-traumatic stress disorder, experts believe that the future is bright for psychedelic drugs that treat mental health conditions.
The Transformative Role of Medical Information in Customer Engagement
October 3rd 2024Stacey Fung, Head of Global Medical Information at Gilead Lifesciences, delves into the evolving role of Medical Information (MI) in the pharmaceutical industry. Covering key topics like patient engagement through omnichannel strategies, combating misinformation, and leveraging AI to enhance medical inquiries, the conversation with Stacey highlights MI's critical role in ensuring patient safety and supporting drug development. She also shares her professional journey and tidbits for early career professionals on professional development.
The Impact of Artificial Intelligence on the Creation of Medicines
October 24th 2024Najat Khan, chief R&D officer, chief commercial officer, Recursion, and Fred Hassan, director, Warburg Pincus, discuss how artificial intelligence can help reduce healthcare costs at the 20th Annual Young & Partners Pharmaceutical Executive Summit held at the Yale Club of New York.